A trial to learn how safe AZD9750 is and how well it works in people with metastatic prostate cancer when given with or without other anticancer drugs

Trial Identifier: D7270C00001
Sponsor: AstraZeneca
Start Date: January 2026
Primary Completion Date: January 2029
Study Completion Date: January 2029
Condition: Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU Melbourne, AU, 3000
CA, Alberta Calgary, Alberta, CA, T2N 5G2
CA, BC Vancouver, BC, CA, V5Z 1H7
CN Chengdu, CN, 610041
ES Barcelona, ES, 8035
GB Cambridge, GB, CB2 2QQ
JP Chuo-ku, JP, 104-0045
JP Kashiwa, JP, 227-8577
NL Amsterdam, NL, 1066CX
NL ROTTERDAM, NL, 3015 GD
US, CA Duarte, CA, US, 91010
US, CA San Francisco, CA, US, 94143
US, FL Tampa, FL, US, 33612
US, MA Boston, MA, US, 02114
US, MO Saint Louis, MO, US, 63108
US, SC Myrtle Beach, SC, US, 29572
US, TN Nashville, TN, US, 37203
US, UT Salt Lake City, UT, US, 84112